For Biolearn, DNAm beta values (ssNoob-normalized) and matched sample metadata were imported into R (v4.2.2)
This article examines the available evidence, explores mechanisms linking GLP-1 receptor agonists to bone health, and provides practical guidance for monitoring and supporting skeletal wellbeing in patients receiving Ozempic
GPX1 Pro198Leu (rs1050450) reduces glutathione peroxidase activity by approximately 30% in Leu/Leu carriers and is associated with cardiovascular and oncologic risk
2 This level of weight reduction is considered clinically meaningful and surpasses results from similar pharmacotherapies for weight management
Artificial Color and Dye Free
In Kansas, optimal candidates for semaglutide weight loss measures typically feature a BMI of 30 or greater or possess a BMI of 27 or more accompanied by weight-related medical issues like hypertension, type 2 diabetes, or cholesterol complications